Search Within

Mario E Lacouture

Formats
  1. Journal Article (220)
  2. Meeting Abstract (171)
  3. Book Section (25)
  4. Review (18)
  5. Research Letter (9)
  6. Guidelines (5)
  7. Book Whole (2)
  8. Conference Paper (2)
  9. Editorial (2)
  10. Miscellaneous (2)
  11. Correspondence (1)
Groups
  1. Department of Medicine (457)
  2. Dermatology (457)
  3. Dermatology Service (457)
  4. Division of Subspecialty Medicine (457)
  5. Survivorship Research (457)
  6. Solid Tumor Oncology Division (142)

More Groups

People
  1. Viswanath Reddy Belum (37)
  2. Shari Goldfarb (34)
  3. Alina Markova (31)
  4. Azael Freites Martinez (27)
  5. Yevgeniy Balagula (26)
  6. Stephen Dusza (25)

More People

Years
  1. 2025 (4)
  2. 2024 (17)
  3. 2023 (24)
  4. 2022 (31)
  5. 2021 (32)
  6. 2020 (27)

More Years

Publications
  1. Journal of Clinical Oncology (90)
  2. Journal of the American Academy of Dermatology (51)
  3. Annals of Oncology (20)
  4. Supportive Care in Cancer (17)
  5. The Oncologist (16)
  6. Blood (12)

More Publications

Publishers
  1. American Society of Clinical Oncology (92)
  2. Mosby Elsevier (55)
  3. Oxford University Press (44)
  4. Elsevier Inc. (35)
  5. Springer (34)
  6. Wiley Blackwell (29)

More Publishers

Results (457)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Noninvasive genomic characterization of patients with nonsclerotic and superficially sclerotic chronic cutaneous graft-versus-host disease identified a novel gene signature in responders to ruxolitinib cream
    Meeting Abstract

    Markova, A.; Whitaker, J. W.; Ai, R.; Pan, A.; Dusza, S.; Lacouture, M. E.; Chowdhury, A.; Perales, M. A.; Prockop, S. E.; Ponce, D. M.
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Oncodermatology: Advancing the science and care of cancer patients and survivors
    Research Letter

    Bang, A. S.; Anadkat, M. J.; Choi, J. N.; LeBoeuf, N. R.; Jung, J. Y.; Markova, A.; Gordon, A.; Rossi, A. M.; Noor, S. J.; Sibaud, V.; more...
    American Journal of Clinical Dermatology (2022)

    Fulltext@MSK | Save
  • Effect of immune checkpoint inhibitors on asthma
    Correspondence

    Wang, E. A.; Goleva, E.; Ketosugbo, K.; Kern, J. A.; Kraehenbuehl, L.; Lacouture, M. E.; Leung, D. Y. M.
    Annals of Allergy, Asthma & Immunology (2022)

    Fulltext@MSK | Save
  • Contribution of the skin–gut axis to immune-related adverse events with multi-system involvement
    Journal Article

    Kuo, A. M.; Kraehenbuehl, L.; King, S.; Leung, D. Y. M.; Goleva, E.; Moy, A. P.; Lacouture, M. E.; Shah, N. J.; Faleck, D. M.
    Cancers (2022)

    Fulltext@MSK | Save
  • Phase 1/2 study of topical submicron particle paclitaxel for cutaneous metastases of breast cancer
    Journal Article

    Lacouture, M. E.; Goldfarb, S. B.; Markova, A.; Chawla, S. P.; Dewnani, K.; Iacobucci, M.; Lang, J. E.
    Breast Cancer Research and Treatment (2022)

    Fulltext@MSK | Save
  • Hypersensitivity reactions to selpercatinib treatment with or without prior immune checkpoint inhibitor therapy in patients with NSCLC in LIBRETTO-001
    Journal Article

    McCoach, C. E.; Rolfo, C.; Drilon, A.; Lacouture, M.; Besse, B.; Goto, K.; Zhu, V. W.; Tan, D. S. W.; Farajian, S.; Potter, L. A.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • Checkpoint inhibition induced pruritus during cancer therapy is associated with skin IL-31 and CCL22 expression
    Meeting Abstract

    Wang, E.; Lyubchenko, T.; Goleva, E.; Kraehenbuehl, L.; Ketosugbo, K.; Moy, A.; Hellmann, M.; Kern, J.; Lacouture, M.; Leung, D.
    Journal of Allergy and Clinical Immunology (2022)

    Fulltext@MSK | Save
  • Ibrutinib-associated dermatologic toxicities: A systematic review and meta-analysis
    Review

    Nocco, S.; Andriano, T. M.; Bose, A.; Chilov, M.; Godwin, K.; Dranitsaris, G.; Wu, S.; Lacouture, M. E.; Roeker, L. E.; Mato, A. R.; more...
    Critical Reviews in Oncology/Hematology (2022)

    Fulltext@MSK | Save
  • A survey study of prevention and treatment patterns by academic and community oncologists for hand-foot skin reaction associated with vascular endothelial growth factor receptor inhibitor (VEGFRi) therapy
    Meeting Abstract

    Lacouture, M. E.; Anadkat, M. J.; Patel, A. B.; Marathe, O. S.; Webb, M. L.; Tyler, R. C.; Chen, L.; Wu, C.; Li, W.; Ju, J.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Part 1 results from NOVA-II, a randomized, double-blind, vehicle-controlled phase II study evaluating the safety and efficacy of OQL011 on VEGFR inhibitor associated hand-foot skin reaction in cancer patients
    Meeting Abstract

    Lacouture, M. E.; Patel, A. B.; Le Boeuf, N. R.; Marathe, O. S.; Leventhal, J.; Choi, J. N.; Lam, E. T.; Kaffenberger, B. S.; Voss, M. H.; Webb, M. L.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save